Advertisement

Topics

Aerpio Pharmaceuticals to Present at the Cowen 38th Annual Health Care Conference

07:00 EST 6 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that Chief Executive Officer, Stephen Hoffman, M.D., Ph.D., will presen...

Other Sources for this Article

Investor:
Aerpio Pharmaceuticals, Inc.
Michael Rogers, CFO
513-985-1958

NEXT ARTICLE

More From BioPortfolio on "Aerpio Pharmaceuticals to Present at the Cowen 38th Annual Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...